Search
Průzkum zainteresovaných stran WHO o zlepšení přístupu k morfinu pro lékařské použití
WHO zahájila průzkum o hodnocení překážek, prostředků umožňujících a pirátských akcí pro zlepšení přístupu k morfinu pro lékařské použití.
Všechny organizace občanské společnosti mohou přispět vyplněním průzkumu do 31. srpna 2022.
Průz...
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Background
In the United States, access to buprenorphine remains low and disparities regarding who receives treatment have emerged. Federal laws have regulated buprenorphine delivery, ultimately limiting its implementation more broadly...
The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis
Background
Beginning in the 1990s, non-medical use of prescription opioids (POs) became a major public health crisis. In response to rising rates of opioid dependence and fatal poisonings, measures were instituted to decrease the...
Addressing drug challenges in health and humanitarian crises: Settings in need of care for a comprehensive drug use prevention in Nigeria
Bi-Monthly Webinar: ISSUP Nigeria Knowledge Update Series (Thirteenth Session)
ISSUP Nigeria would like to invite you to attend their next Bi-Monthly Webinar in the Knowledge Update Series. The Webinar topic will be Beyond Dependence: Alcohol-induced Disorders.
Learning Outcomes:
• Sensitization to the wide...
Treating co-occurring substance use and mental health disorders using tools from CBT
Presented by Jo Cassar (The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney), by the end of this webinar, attendees will be able to:
- Recognise the importance of assessing for substance use when a...
Eating disorders and AOD use: what clinicians need to know
Presented by Associate Professor Sarah Maguire (Director, InsideOut Institute), by attending this webinar, attendees will learn:
- How to recognise the most common eating disorder symptoms;
- Eating disorder interventions and how...
Kenya to include smoking cessation drugs as essential medicines
The Ministry of Health has been advised to add two non-nicotine drugs to Kenya’s Essential Medicines List, to help smokers quit tobacco and nicotine addiction.
The World Health Organization said the two drugs bring “a powerful shift in...
Multiple disadvantage and co-occurring substance use and mental health conditions.
Substance use and mental health needs are two of the primary concerns for many people experiencing multiple disadvantage. We know that people who experience both issues at the same time (also known as “co-occurring conditions” or “dual...
The impact of discrimination on substance use disorders among sexual minorities
This paper aimed to review the literature regarding the impact of discrimination on substance use disorders among Sexual Minorities, with a focus on alcohol, opioids, stimulants, polydrug use, chemsex, cannabis and tobacco, as well as...
The cardiovascular risks and benefits of quit smoking medicines
In this presentation, the speakers reported the results of a series of three population-based cohort studies relating to the use and effects of smoking cessation pharmacotherapies. The first of these studies provided evidence on how the...
Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth
Abstract
Importance Prenatal smoking is a known modifiable risk factor for stillbirth; however, the contribution of prenatal drinking or the combination of smoking and drinking is uncertain.
Objective To examine whether prenatal...
Accreditation of Study Programs on Addictions in Nigerian Universities: Challenges, Opportunities, and the Need for Advocacy
INTRODUCTION:
Access to drug treatment services in Nigeria remains low due to a severe shortage in the drug treatment workforce. Plans are underway to address the workforce shortage by introducing drug addiction training programs in...
Série webinářů o nových psychoaktivních látkách (NPS)
Různé NPS významně změnily obraz užívání drog v různých zemích. Nyní jsou na trhu s drogami velmi prominentní. Mnohé z těchto látek jsou skutečně určeny k obcházení protidrogových zákonů a jsou prodávány jako "legální" náhrady konopí...
The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis
New Psychoactive Substances: Reading List
Project NEPTUNE training modules
In partnership with the Royal College of Psychiatrists, Project NEPTUNE has developed training modules to improve clinical practice in the management of harms resulting from the use of club drugs and novel psychoactive substances.
These...
Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances
This document provides guidance on the clinical management of harms resulting from acute intoxication and from the harmful and dependent use of club drugs and Novel Psychoactive Substances (NPS).
This is an extensive and comprehensive...
Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS
Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the...
Novel Psychoactive Substances: Policy, Economics and Drug Regulation
In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member